Alzheimer's disease drug development pipeline: 2021

INTRODUCTION: The number of individuals worldwide with Alzheimer's disease (AD) is growing at a rapid rate. New treatments are urgently needed. We review the current pipeline of drugs in clinical trials for the treatment of AD. METHODS: We interrogated ClinicalTrials.gov, the federal registry o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Lee, Garam, Zhong, Kate, Fonseca, Jorge, Taghva, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145448/
https://www.ncbi.nlm.nih.gov/pubmed/34095440
http://dx.doi.org/10.1002/trc2.12179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145448/
https://www.ncbi.nlm.nih.gov/pubmed/34095440
http://dx.doi.org/10.1002/trc2.12179

Ejemplares similares